EMBO Molecular Medicine

Papers
(The H4-Index of EMBO Molecular Medicine is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
IL‐27 produced during acute malaria infection regulates Plasmodium‐specific memory CD4+ T cells281
Tumor‐associated macrophages‐educated reparative macrophages promote diabetic wound healing221
Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts163
Comparison of tumor‐informed and tumor‐naïve sequencing assays for ctDNA detection in breast cancer119
Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders108
miR‐9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC106
Combinatorial activation of the WNT‐dependent fibrogenic program by distinct complement subunits in dystrophic muscle100
Pdia4 regulates β‐cell pathogenesis in diabetes: molecular mechanism and targeted therapy98
Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients94
Adaptively evolved human oral actinomyces‐sourced defensins show therapeutic potential93
External validity in translational biomedicine: understanding the conditions enabling the cause to have an effect76
FIBCD1 is an endocytic GAG receptor associated with a novel neurodevelopmental disorder72
PI3Kα targeting, nipping pancreatic cancer evolution in the bud72
Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis71
Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics68
Lifting the iron curtain of vision67
The genetic regulation of protein expression in cerebrospinal fluid63
SARS‐CoV ‐2 spike protein enhances MAP4K3 / GLK ‐induced ACE2 stability 62
Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination59
Whole‐brain microscopy reveals distinct temporal and spatial efficacy of anti‐Aβ therapies59
Metabolic switch from fatty acid oxidation to glycolysis in knock‐in mouse model of Barth syndrome58
Targeting CD301+ macrophages inhibits endometrial fibrosis and improves pregnancy outcome58
Dependence receptors: new targets for cancer therapy55
Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors50
Promoters of ASCL1‐ and NEUROD1‐dependent genes are specific targets of lurbinectedin in SCLC cells49
Liver gene therapy with intein‐mediated F8 trans ‐splicing corrects mouse haemophilia A46
PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice43
Immunological barriers to immunotherapy in primary and metastatic breast cancer43
FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice43
From netrin‐1‐targeted SPECT/CT to internal radiotherapy for management of advanced solid tumors42
CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma41
CD38‐NADase is a new major contributor to Duchenne muscular dystrophic phenotype41
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ‐secretase activity39
Circulating proteomic panels for risk stratification of intracranial aneurysm and its rupture39
M‐CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation39
In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues38
A high‐resolution 3D atlas of the spectrum of tuberculous and COVID ‐19 lung lesions38
Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity38
0.092592000961304